-
Symbol
-
BDTX on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Shares Owned
-
2,733,547 shares
-
Security Ownership %
-
4.8%
BB Biotech AG ownership in Black Diamond Therapeutics, Inc. Common Stock, par value $0.0001 per share (BDTX)
21 Mar 2025 - BB Biotech AG has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,733,547 shares of Black Diamond Therapeutics, Inc. Common Stock, par value $0.0001 per share (BDTX).
This represents 4.8% ownership of the company.
In their previous filing dated 14 Feb 2025, BB BIOTECH AG had reported owning 8,517,839 shares, indicating a decrease of +68%.
.